Objective: This blinded, randomized controlled trial assessed the effectiveness of a personalized, spectrally altered music-based sound therapy over 12 months of use. Method: Two groups of participants (n = 50) were randomized to receive either altered or unaltered classical music. The treatment group received classical music that had been modified based on spectral alterations specific to their tinnitus characteristics. Tinnitus and psychological functioning were assessed at baseline and 3, 6, and 12 months after initial testing using self-reports. Participants, investigators and research assistants were blinded from group assignment. Results: Data from 34 participants were analyzed. The treatment group reported significantly lower levels of tinnitus distress (primary outcome, assessed using the Tinnitus Handicap Inventory) than the control group throughout the follow-up period. Among the treatment group, there were statistically significant and clinically meaningful levels of reduction in tinnitus distress, severity, and functional impairment at 3- and 6-month follow-ups, which was sustained at the 12-month follow-up. Conclusion: The personalized music therapy was effective in reducing subjective tinnitus and represents a meaningful advancement in tinnitus intervention.

Keywords:
Tinnitus, Sound therapy, Music therapy, Brain plasticity, Computational model
1.
Argstatter H, Grapp M, Hutter E, Plinkert P, Bolay HV: Long-term effects of the ‘Heidelberg Model of Music Therapy' in patients with chronic tinnitus. Int J Clin Exp Med 2012;5:273-288.
2.
Auerbach BD, Rodrigues PV, Salvi RJ: Central gain control in tinnitus and hyperacusis. Front Neurol 2014;5:1-21.
3.
Baguley D, McFerran D, Hall D: Tinnitus. Lancet 2013;382:1600-1607.
4.
Bjelland I, Dahl AA, Haug TT, Neckelmann D: The validity of the hospital anxiety and depression scale: an updated literature review. J Psychosom Res 2002;52:69-77.
5.
Davis PB, Wilde RA, Steed LG, Hanley PJ: Treatment of tinnitus with a customized acoustic neural stimulus: a controlled clinical study. Ear Nose Throat J 2008;87:330-339.
6.
Grapp M, Hutter E, Argstatter H, Plinkert PK, Bolay HV: Music therapy as an early intervention to prevent chronification of tinnitus. Int J Clin Exp Med 2013;6:589-593.
7.
Herrmann C: International experiences with the hospital anxiety and depression scale - a review of validation data and clinical results. J Psychosom Res 1997;42:17-41.
8.
Herzfeld M, Ciurlia-Guy E, Sweetow R: Clinical trial on the effectiveness of Widex Zen Therapy for tinnitus. Hear Rev 2014;21:24-29.
9.
Hoare DJ, Kowalkowski VL, Kang S, Hall DA: Systematic review and meta-analyses of randomized controlled trials examining tinnitus management. Laryngoscope 2011;121:1555-1564.
10.
Hoare DJ, Pierzycki RH, Thomas H, McAlpine D, Hall DA: Evaluation of the acoustic coordinated reset (CR®) neuromodulation therapy for tinnitus: study protocol for a double-blind randomized placebo-controlled trial. Trials 2013;14:207.
11.
Hoare DJ, Searchfield GD, Refaie AE, Henry JA: Sound therapy for tinnitus management: practicable options. J Am Acad Audiol 2014;25:62-75.
12.
Jastreboff PJ, Jastreboff MM: Tinnitus retraining therapy: a different view on tinnitus. ORL J Otorhinolaryngol Relat Spec 2006;68:23-29; discussion 29-30.
13.
Koelsch S: A neuroscientific perspective on music therapy. Ann NY Acad Sci 2009;1169:374-384.
14.
Landgrebe M, Langguth B: Tinnitus and anxiety; in Møller AR, Langguth B, DeRidder D, Kleinjung T (eds): Textbook of Tinnitus. New York, Springer, 2011, pp 499-503.
15.
Meikle MB, Henry JA, Griest SE, Stewart BJ, Abrams HB, McArdle R, Myers PJ, Newman CW, Sandridge S, Turk DC, Folmer RL, Frederick EJ, House JW, Jacobson GP, Kinney SE, Martin WH, Nagler SM, Reich GE, Searchfield G, Sweetow R, Vernon JA: The tinnitus functional index: development of a new clinical measure for chronic, intrusive tinnitus. Ear Hear 2012;33:153-176.
16.
Newman CW, Jacobson GP, Spitzer JB: Development of the tinnitus handicap inventory. Arch Otolaryngol Head Neck Surg 1996;122:143-148.
17.
Pantev C, Okamoto H, Teismann H: Tinnitus: the dark side of the auditory cortex plasticity. Ann NY Acad Sci 2012;1252:253-258.
18.
Roberts LE, Eggermont JJ, Caspary DM, Shore SE, Melcher JR, Kaltenbach JA: Ringing ears: the neuroscience of tinnitus. J Neurosci 2010; 30:14972-14979.
19.
Roberts LE, Moffat G, Baumann M, Ward LM, Bosnyak DJ: Residual inhibition functions overlap tinnitus spectra and the region of auditory threshold shift. J Assoc Res Otolaryngol 2008;9:417-435.
20.
Seki S, Eggermont JJ: Changes in spontaneous firing rate and neural synchrony in cat primary auditory cortex after localized tone-induced hearing loss. Hear Res 2003;180:28-38.
21.
StataCorp: Stata Statistical Software, release 12. College Station, StataCorp LP, 2011.
22.
Sun W, Deng A, Jayaram A, Gibson B: Noise exposure enhances auditory cortex responses related to hyperacusis behavior. Brain Res 2012;1485:108-116.
23.
Tyler R, Stocking C, Secor C, Slattery WH III: Amplitude modulated S-tones can be superior to noise for tinnitus reduction. Am J Audiol 2014;23:303-308.
24.
Yang S, Weiner BD, Zhang LS, Cho S-J, Bao S: Homeostatic plasticity drives tinnitus perception in an animal model. Proc Natl Acad Sci USA 2011;108:14974-14979.
25.
Zeman F, Koller M, Figueiredo R, Aazevedo A, Rates M, Coelho C, Kleinjung T, de Ridder D, Langguth B, Landgrebe M: Tinnitus handicap inventory for evaluating treatment effects: which changes are clinically relevant? Otolaryngol Head Neck Surg 2011;145:282-287.
26.
Zigmond AS, Snaith RP: The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67:361-370.
© 2016 S. Karger AG, Basel
2016
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.